Thus, androgen deprivation is the ideal treatment strategy for patients with advanced and metastatic prostate cancer [13]. Vitamin D receptors, on the other hand, are expressed in Leydig cells, Sertoli cells, and seminiferous tubules and are involved in the androgen signaling mechanism. This evidence concerns the gene VDR and metastatic prostate carcinoma.